LivingGLP1
Study S000328

The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)

Registration

Registration
NCT07298915
Acronym
EXER-MED
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE3
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
24
Start
2026-08
Primary completion
2026-12
Lead sponsor
University of Virginia
Conditions
Obesity & Overweight
Interventions
DRUG:Tirzepatide; BEHAVIORAL:Exercise
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Weight [Baseline and 16 Weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.